Abstract. Antisera against proline rich peptide P-C, recently isolated from human whole saliva were raised in rabbits by injections of peptide P-C-BSA conjugates. Immunohistochemical study using the antisera was carried out on human salivary glands, gut and pancreas. The results showed that peptide P-C like immunoreactivity was present not only in the salivary glands but also in the pancreatic islets, though not in the gut. Furthermore, immunostaining of adjacent thin sections revealed that cells reacting with antisera against peptide P-C were identical to those reacting with insulin antisera. As the antisera against peptide P-C did not have any cross-reactivities to insulin, glucagon, somatostatin, pancreatic polypeptide, VIP and human C-peptide, the antisera were considered to recognize specifically either peptide P-C related antigen or peptide P-C itself in human pancreatic B-cells 
Recently, Isemura et al. (1979) isolated the proline rich peptide P-C from human whole saliva. Al¬ though the primary structure of this peptide as shown in Fig. 1 was also presented by this group (Isemura et al. 1980) , the pathophysiological roles and distribution in the tissues of this peptide re¬ mained obscure.
Amylase and kallikrein were detected in tissues of both the pancreas and the salivary glands (OleMoi-Yoi et al. 1979; 0rstavik et al. 1980 ). Glucagon, originally isolated from the pancreas, was later found in the salivary glands (Lawrence et al. 1977 ). These findings, therefore, suggested that peptide P-C may also be present in the pancreas. Quite re¬ cently, we succeeded in preparing antisera against peptide P-C. By immunohistochemical study using these antisera, it was revealed that cells reacting with the antisera against peptide P-C were present in human pancreatic islets. Furthermore, from observations of serial thin sections immunostained with antisera against insulin, glucagon, somatosta¬ tin, porcine pancreatic polypeptide, and antisera against peptide P-C, it was found that peptide P-C like immunoreactivity was present only in the pan¬ creatic B-cells. This paper deals with the details of the immuno- The primary structure of proline rich peptide P-C. histochemical study on the detection of peptide P-C like immunoreactivity in human salivary glands and pancreatic B-cells.
Materials and Methods

Antisera
Antisera against proline rich peptide P-C were raised in rabbits by injection of peptide P-C-BSA conjugates which had been prepared from isolated peptide P-C and BSA using glutaraldehyde. The conjugation of peptide P-C with BSA was carried out as follows. To the solution of 1.5 ml of 0.1 M borate buffer pH 9.5 containing 4 mg of BSA, 2 mg of peptide P-C and 0.1 ml of 1% glutaralde¬ hyde were added. The mixture was allowed to react at room temperature for 2 h and was dialysed against 1000 ml of 0.9% NaCl at 4°C overnight. The solution contain¬ ing peptide P-C-BSA conjugates was then emulsified with Freund's complete adjuvant and injected into 3 rabbits at 40 day intervals. After two boosters, 1 mg of peptide P-C emulsified with Freund's incomplete adjuvant was in¬ jected into 3 rabbits. Antisera used in the present study were obtained 10 days after the fourth injection. Before use of the antisera in radioimmunoassay and immunocytochemistry, 10 ml of antisera was incubated with 20 mg of BSA for 2 days and centrifuged at 3000 r. p. m.
for 25 min at 4°C to remove any contamination by antisera against BSA. Furthermore, to avoid possible non-specific reactions between unknown substances in the tissues and unknown components in sera, antisera against peptide P-C were purified to rabbit immunoglobulin by using DEAE-cellulose column chromatography in which 0.01 M phosphate buffer pH 8.0 was used as the elution buffer. The anti-peptide P-C rabbit immunoglobulin, thus prepared, was used in radioimmunoassay and immunocytochemistry.
Antisera against glucagon, somatostatin and porcine pancreatic polypeptide were raised in rabbits. Details of preparation of the former two antisera were previously reported (Ito et al. 1981 (Ito et al. , 1982 (Isemura et al. 1979 ).
Radioimmunoassay
The titres of antisera against peptide P-C raised in 3 rabbits were determined as follows. Labelled peptide P-C (50 pg), 500 units of trasylol and diluted antisera were incubated in plastic tubes at 4°C for 2 days. Dextrancoated charcoal was then added to these tubes to separate the antisera bound peptide P-C from the free peptide P-C. The tubes were centrifuged at 4°C for 25 min at 3000 rp.
m. The supernatants and precipitates were separated and the latter was counted for 2 min in a deep well automatic gamma counter (Aroka ARC-251). Antisera against peptide P-C were raised in all 3 rabbits immunized. Titres of these antisera were 1:6000, 1:8000, and 1:24 000 (Abs3), respectively. To examine the speci¬ ficity of these antisera against peptide P-C, the crossreactivity of the antisera to other peptides including monocomponent porcine insulin, glucagon, porcine pp Typical standard curve of the peptide P-C in radioimmunoassay using Abs3. The antisera against peptide P-C (Abs3) has a negligible cross-reactivity to other peptides as shown by the horizontal bars.
(Novo Institute) somatostatin-14 and -28, VIP (Peninsula Laboratories), met-enkephalin, leu-enkephalin, ß-endor¬ phin, TRH (Protein Research Foundatiuon Osaka, Japan), human C-peptide and 1_18ACTH (Shionogi Co. Ltd.) and kallikrein (gift from Prof. Yanaihara) was studied by radioimmunoassay. Labelled peptide P-C, diluted antisera against peptide P-C which bind 50-60% of labelled peptide P-C, standard peptide P-C or other peptides were incubated at 4°C for 2 days in plastic tubes which contained 500 units of trasylol. In this system, 0.1 M phosphate buffer pH 7.4 containing 0.25% of BSA and 0.05% NaN3 were used as assay buffer. After separa¬ tion of antisera bound peptide P-C from free peptide P-C by addition of dextran-coated charcoal and centrifuga¬ tion, the precipitates were counted for 2 min in a deep well gamma counter. Fig. 2 shows the typical standard curve of peptide P-C in radioimmunoassay and the cross-reactivities of the antisera against peptide P-C to other peptides. The antisera had no cross-reactivities to other peptides. were separately incubated with diluted antisera against peptide P-C at 4°C for 3 days. Antisera bound labelled insulin or human C-peptide were then separated from antisera free labelled porcine insulin or human C-pep¬ tide by the addition of dextran-coated charcoal and centrifugation. Contamination by insulin and human C-peptide antisera was not detected in the antisera against peptide P-C.
Immunohistochemistry
Immunohistochemial studies were carried out on the adult human submaxillary, sublingual and parotid glands; gut including the stomach, duodenum, jejunum, ileum and colon, and pancreas. Adult human gut was obtained from patients with stomach cancer, stomach ulcer, intestinal and colon cancer during operations and adult human pancreata were obtained from 3 patients with stomach cancer at operation. The human salivary glands were obtained from cadavers whose death was due to pneumonia. These tissues were fixed in 10% Fig. 3 .
Sections of parotid glands stained by haematoxylin-eosin (Fig. 3a) and immunostained with antisera against peptide P-C (Fig. 3b) . Almost all of the cells in the serous acini were positively stained by using antisera against peptide P-C. The peptide P-C positive cells were not found in the duct. The adjacent section of Fig. 3b . When the antisera against peptide P-C pre-incubated with peptide P-C were employed to replace the primary antisera, the peptide P-C positive cells disappeared (Fig. 3c) . (X 310).
formalin and Bouin's solution for 12 and 5 h, respecti¬ vely, and embedded into paraffin. Serial thin sections, 2 µ thick were used in an indirect immunofluorescence technique (Coons et al. 1955 ). In brief, ten serial thin sections were incubated with normal porcine serum di¬ luted to 1:20 at room temperature for 45 min to remove non-specific reactions between unknown substances in the tissues and unknown components in the sera. They were then allowed to react with the following primary antisera: a) 1:100 diluted antisera against peptide P-C, b) 1:100 diluted antisera against peptide P-C pre-absorbed with 5 pg of peptide P-C, c) 1:1500 diluted pp antisera, d) 1:100 diluted antisera against peptide P-C pre-incubated with 5 pg insulin, e) 1:200 diluted insulin antisera, f) 1:100 diluted antisera against peptide P-C pre-treated with 5 pg human C-peptide, g) 1:100 diluted glucagon antisera, h) 1:100 diluted antisera against peptide P-C pre-absorbed with 5 µg kallikrein, i) 1:300 diluted somatostatin antisera, j) 1:100 diluted antisera agianst peptide P-C pre-incubated with 5 µg of glucagon, somatostatin, and pp. pletely inhibited after pre-treatment of the antisera against peptide P-C with peptide P-C. From obser¬ vation of serial thin sections immunostained with four kinds of antisera against insulin, glucagon, Fig. 4 . Immunofluroescent cells reacting with antisera against peptide P-C (a), with antisera against peptide P-C pre-incubated with peptide P-C (b), with pp antisera (c), with antisera against peptide P-C pre-incubated with insulin (d), with insulin antisera (e), with antisera against peptide P-C pre-treated with human C-peptide (f), with glucagon antisera (g), with antisera against peptide P-C pre-absorbed with kallikrein (h), with somatostatin-14 antisera (i) and with antisera against peptide P-C pre-incubated with somatostatin, pp and glucagon (j). The peptide P-C positive cells were identical to the insulin positive ones. Bright immunofluroesence disappeared in sections in which the antisera against peptide P-C pre-absorbed with peptide p-C were used to replace primary antisera in the immunohistochemical staining process.
(x 280).
somatostatin, pp and the antisera against peptide P-C, it was revealed that the cells reacting with the antisera against peptide P-C were not identical to glucagon-. somatostatin-, and pp-containing cells but to insulin-containing B-cells as seen in Fig. 4a , 4b, 4c, 4d, 4e, 4f, 4g, 4h, 4i and 4j. When normal rabbit serum was used as the primary antisera in the immunohistochemical staining process, no specifically immunostained cells were found.
Discussion
The present study showed that peptide P-C like immunoreactivity is present not only in human salivary glands but also in human pancreatic B- cells. Radioimmunoassay demonstrated that the antisera against peptide P-C did not have any cross-reactivity with other well known peptides including insulin, human C-peptide, glucagon, somatostatin, pancreatic polypeptide, kallikrein, met-enkephalin, leu-enkephalin, ß-endorphin, TRH and ACTH. In the immunohistochemical study, pre-treatment of the antisera against peptide P-C with the other well known peptides mentioned above did not inhibit detection of peptide P-C like immunoreactivity. Furthermore, titres of antisera against insulin and human C-peptide were not detected in the antisera against peptide P-C by using [125I]insulin and [125I]human C-peptide, respectively. Therefore, it seems reasonable to think that detection of peptide P-C like immuno¬ reactivity was not due to immunohistochemical cross-reactions between the antisera against pep¬ tide P-C and the other well known peptides men¬ tioned above, but due to those either between the antisera against peptide P-C and peptide P-C itself, or between the antisera against peptide P-C and peptide P-C related antigen. Thus, it seems likely that peptide P-C like immunoreactivity in the pan¬ creatic B-cells is present independently from sub¬ stances which are known to be related to the synthesis of human insulin.
There are several findings which suggest func¬ tional similarities between the pancreas and the salivary glands. Amylase is secreted from the exocrine glands of the pancreas and the salivary glands. Kallikrein detected in the salivary glands was later found in the pancreas (Ole-Moi-Yoi et al. 1979) . Glucagon, originally isolated from the pancreas was also de¬ tected in the salivary glands (Lawrence et al. 1977 ).
Furthermore, morphological similarities between the exocrine glands of the pancreas and those of the salivary glands have been observed using the light and electron microscopes (Parks 1962 (Zelman 1944) . Hypertrophy of the parotid glands was found in patients with chronic pancreatitis with stone (Alappatt & Ananthachari 1967) . The secre¬ tion of amylase from the salivary glands decreased in patients with chronic pancreatitis (Deseos et al. 1973; Kakizaki et al. 1976 ). In view of these physio¬ logical, morphological and pathological relations between the pancreas and the salivary glands, it is not surprising that peptide P-C like immunoreac¬ tivity, originally isolated from human whole saliva, was present in the human pancreatic B-cells. Thus, detection of peptide P-C like immunoreactivity in the human pancreas seems to be a new addition to the evidence supporting the presence of pathophy¬ siological relations between the pancreas and the salivary glands.
Recently, Wong & Bennick (1980) presented the primary structure of a proline rich phosphoprotein named Salivary Protein C which was isolated from parotid saliva by Bennick & Connell (1971) . The protein consists of a single polypeptide chain of 150 residues. Analysis of the amino acid sequence of Salivary Protein C revealed that the COOHterminal 44 residues were identical to the full sequence of peptide P-C isolated from human whole saliva by Isemura et al. (1979) . Based on his finding, it was suggested that peptide P-C like immunoreactivity in the human pancreatic B-cells may belong to Salivary Protein C. Further study will be necessary to elucidate whether peptide P-C like immunoreactivity in the human pancreatic B-cells is peptide P-C itself or a moiety of Salivary Protein C.
It is not clear why peptide P-C like immunore¬ activity is present in pancreatic B-cells, However, it seems likely that this peptide may play some role in the function of pancreatic B-cells since it was present only in B-cells of the four kinds of cells in the islets. It has been suggested that, in saliva, acidic proline rich proteins aid in maintenance of the calcium concentration (Bennick & Cannon 1978) .
If peptide P-C like immunoreactivity in the pan-creatic B-cells belongs to a moiety of Salivary Protein C in other words, if Salivary Protein C is present in the human pancreatic B-cells, Protein C in the B-cells may aid in maintenance of the cal¬ cium concentration in the B-cells. The speculation together with the fact that calcium plays an im¬ portant role in the secretion of insulin, leads to the possibility that peptide P-C like immunoreactivity in the pancreatic B-cells may play some role in the secretion of insulin, though the exact pathophysiological role of this P-C like immunoreactivity in the pancreatic B-cells remains obscure.
